13774214275
13774214275
产品中心
当前位置：首页
产品中心抗体/抗原Biosimilar抗体S0B0437Bevacizumab
相关文章
Bevacizumab works by blocking a protein called VEGF, which some cancer cells produce in large amounts. Blocking VEGF may prevent the growth of new blood vessels that tumors need to grow. Bevacizumab is a type of targeted therapy called an angiogenesis inhibitor. For cancer, it is given by slow injection into a vein （intravenous） and used for colon cancer, lung cancer, glioblastoma, and renal-cell carcinoma. In many of these diseases it is used as a first-line therapy. For age-related macular degeneration it is given by injection into the eye （intravitreal）.
产品型号：
更新时间：
厂商性质：
访问量：
上一个：
返回列表
